InsidersTradesSigma
Follow the 大幸薬品株式会社 stock price and the full management transaction log of the company, a listed equity based in Japan. Shares trade on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 大幸薬品株式会社 has published 11 insider filings. Market capitalisation: €12.7bn. The latest transaction was reported on 20 October 2023 (Holding update). Among the most active insiders: Nomura Securities Co.,Ltd.. Every trade is accessible without an account.
11
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,208 of 29,286 companies
70.5
score / 100
Value64
Quality77
FCF yld4.0%
Earn yld7.3%
EV/EBITDA11.1x
ROE20%
Gross mgn54%
Net mgn14%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 October 2023
Declarations11 total
ShareXTKSEDINET:S100S1ZX
ShareXTKSEDINET:S100RQNN
0.1% of flowShareXTKSEDINET:S100RQ8G
0.1% of flowShareXTKSEDINET:S100RQ56
99.8% of flowShareXTKSEDINET:S100RF9A
ShareXTKSEDINET:S100RC5A
18.9% of flowShareXTKSEDINET:S100QX4P
13.7% of flowShareXTKSEDINET:S100QULE
15.8% of flowShareXTKSEDINET:S100QO8P
24.6% of flowShareXTKSEDINET:S100QNHZ
27.0% of flowShareXTKSEDINET:S100QGYI
11 of 11 declarations
About 大幸薬品株式会社
Daiichi Pharmaceutical Co., Ltd. is a Japanese company specializing in the health and pharmaceutical sector. It is listed on the Tokyo Stock Exchange under the symbol XTKS.